Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rhoen Klinikum AGWBO:RHK 77 Return-on-Tangible-Asset is 2.18% as of Jun. 2026, which is 15% below its 10-year median of 2.57. GuruFocus rates WBO:RHK with a GF Score™ of 77/100 and a GF Value™ of €13.71 (Fairly Valued). The stock has 7 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Rhoen Klinikum AG ranks better than 50.37% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Rhoen Klinikum AG's annualizedNet Income for the quarter that ended in Jun. 2026 was €36 Mil. Rhoen Klinikum AG's average total tangible assets for the quarter that ended in Jun. 2026 was €1,659 Mil. Therefore, Rhoen Klinikum AG's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 2.18%.
The historical rank and industry rank for Rhoen Klinikum AG's Return-on-Tangible-Asset or its related term are showing as below:
WBO:RHK'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 0.1 Med: 2.57 Max: 4.1
Current: 2.52
During the past 13 years, Rhoen Klinikum AG's highest Return-on-Tangible-Asset was 4.10%. The lowest was 0.10%. And the median was 2.57%.
WBO:RHK's Return-on-Tangible-Asset is ranked better than 50.37% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 2.43
vs WBO:RHK: 2.52
Rhoen Klinikum AG (WBO:RHK) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Rhoen Klinikum AG Return-on-Tangible-Asset Related Terms
Rhoen Klinikum AG Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Rhoen Klinikum AG's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:RHK vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Rhoen Klinikum AG's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhoen Klinikum AG Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Rhoen Klinikum AG's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 2.18% mean?
Rhoen Klinikum AG (WBO:RHK) has a Return-on-Tangible-Asset of 2.18% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Rhoen Klinikum AG and its competitors. This is 15% below median its historical median of 2.57. Over the past decade, Rhoen Klinikum AG's Return-on-Tangible-Asset has ranged from 0.10 to 4.10. According to the industry distribution chart, Rhoen Klinikum AG ranks #339 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 49.6%.
Is Rhoen Klinikum AG's Return-on-Tangible-Asset too high?
Rhoen Klinikum AG's current Return-on-Tangible-Asset of 2.18% is 15% below median its 10-year median of 2.57. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 4.10. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.43. Rhoen Klinikum AG's value of 2.18% is 10.3% below this industry median. Based on the distribution chart, Rhoen Klinikum AG ranks #339 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Rhoen Klinikum AG has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Rhoen Klinikum AG ranks #339 out of 683 companies for Return-on-Tangible-Asset. This puts Rhoen Klinikum AG in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.43. Rhoen Klinikum AG's value of 2.18% is 10.3% below this benchmark. Historically, Rhoen Klinikum AG's own Return-on-Tangible-Asset has ranged from 0.10 to 4.10 over the past decade. While the company's 10-year median is 2.57 vs. the industry median of 2.43, Rhoen Klinikum AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.43, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhoen Klinikum AG's current Return-on-Tangible-Asset of 2.18% is 10.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Rhoen Klinikum AG and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhoen Klinikum AG's current Return-on-Tangible-Asset is 2.18%, which is 15% below median its own 10-year median of 2.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Based on GuruFocus' analysis, Rhoen Klinikum AG (WBO:RHK) is currently considered Fairly Valued. The stock's GF Value™ is €13.71, compared to a current price of €14.70 — trading 7.2% above its estimated fair value. The current Return-on-Tangible-Asset is 2.18%, which is 15% below median its 10-year median of 2.57 and 10.3% below the Healthcare Providers & Services industry median of 2.43. Rhoen Klinikum AG's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Rhoen Klinikum AG (WBO:RHK), the current Return-on-Tangible-Asset is 2.18% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rhoen Klinikum AG (WBO:RHK) Overvalued in 2026?
Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be overvalued.
The current stock price of €14.70 is trading 7.2% above its estimated GF Value™ of €13.71.
GuruFocus considers Rhoen Klinikum AG to be Fairly Valued.
Key valuation signals for WBO:RHK:
Return-on-Tangible-Asset: 2.18% (15% below median its 10-year median of 2.57)
GF Value™: €13.71 vs. price of €14.70 (7.2% above fair value)
Industry Position: 10.3% below the Healthcare Providers & Services median (#339 of 683)
No single metric tells the full story. See the WBO:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
77GF Score
Get the complete analysis for WBO:RHK
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:RHK has been successfully added to your 
